About 4D Medicine
4D Medicine is a company based in Birmingham (United Kingdom) founded in 2018 by Andrew Dove.. 4D Medicine has raised $6.6 million across 2 funding rounds from investors including DSW Ventures, SFC Capital and Boundary Capital Partners. 4D Medicine offers products and services including 4Degra® and Bioabsorbable Interference Screw. 4D Medicine operates in a competitive market with competitors including CELLINK, Checkerspot, OxSyBio, Collplant and Fermbox, among others.
- Headquarter Birmingham, United Kingdom
- Founders Andrew Dove
-
Sectors
HealthcareTechnology Chemicals & Materials
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name 4D Biomaterials Ltd
- Date of Incorporation 12 Jul, 2023
- Jurisdiction NOTTINGHAM, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.6 M (USD)
in 2 rounds
-
Latest Funding Round
$4.39 M (USD), Series A
Jul 25, 2024
-
Investors
DSW Ventures
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of 4D Medicine
4D Medicine offers a comprehensive portfolio of products and services, including 4Degra® and Bioabsorbable Interference Screw. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Patented polymer for bioabsorbable medical devices.
Device for surgical fixation using biodegradable materials.
Funding Insights of 4D Medicine
4D Medicine has successfully raised a total of $6.6M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4.39 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $4.4M
-
First Round
First Round
(28 Jul 2021)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2024 | Amount | Series A - 4D Medicine | Valuation | Oshen | |
| Jul, 2021 | Amount | Seed - 4D Medicine | Valuation | DSW Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in 4D Medicine
4D Medicine has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include DSW Ventures, SFC Capital and Boundary Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is invested in early-stage UK regional startups.
|
Founded Year | Domain | Location | |
|
Introductions between investors and early-stage companies are facilitated for funding.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by 4D Medicine
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - 4D Medicine
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
4D Medicine Comparisons
Competitors of 4D Medicine
4D Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CELLINK, Checkerspot, OxSyBio, Collplant and Fermbox, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
3D bioprinters and bioinks are developed for research applications.
|
|
| domain | founded_year | HQ Location |
High-performance materials are developed using synthetic biology for diverse applications.
|
|
| domain | founded_year | HQ Location |
Provider of 3D printing of tissue biomaterials for medical research and clinical applications
|
|
| domain | founded_year | HQ Location |
Plant-derived collagen is developed for tissue repair and 3D bioprinting.
|
|
| domain | founded_year | HQ Location |
Alternative animal products are developed via microbial precision fermentation.
|
|
| domain | founded_year | HQ Location |
3D tissue engineering technology is developed for regenerative medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about 4D Medicine
When was 4D Medicine founded?
4D Medicine was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Where is 4D Medicine located?
4D Medicine is headquartered in Birmingham, United Kingdom. It is registered at Birmingham, England, United Kingdom.
Who is the current CEO of 4D Medicine?
Phil Smith is the current CEO of 4D Medicine.
Is 4D Medicine a funded company?
4D Medicine is a funded company, having raised a total of $6.6M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2.21M, raised on Jul 28, 2021.
What does 4D Medicine do?
4D Medicine was established in 2018 in Birmingham, United Kingdom, within the biotechnology sector. Transformative gene therapies targeting serious unmet medical needs are researched, developed, and commercialized. Operations extend to two subsidiaries focused on advancing non-invasive, quantitative lung function imaging and analysis technologies. Activities emphasize clinical applications for respiratory diagnostics and therapeutic innovations in the healthcare domain.
Who are the top competitors of 4D Medicine?
4D Medicine's top competitors include Checkerspot, Cyfuse and Collplant.
What products or services does 4D Medicine offer?
4D Medicine offers 4Degra® and Bioabsorbable Interference Screw.
Who are 4D Medicine's investors?
4D Medicine has 6 investors. Key investors include DSW Ventures, SFC Capital, Boundary Capital Partners, Oshen, and Midlands Engine Investment Fund.